Skip to content
S554Senate2023-2024 SessionSame asA3433

Keep Stem Cell Board

Official title

“Relates to the continuation of the empire state stem cell board”

Sponsor Brad Hoylman-SigalSD-47+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill removes the expiration date for the empire state stem cell board, allowing it to continue operating indefinitely.

Why it matters

  1. Ensures continued state funding and support for stem cell research. , which can accelerate medical breakthroughs in areas like regenerative medicine, genetic disorders, and chronic diseases, potentially improving patient outcomes in New York.

  2. Creates stability for researchers and institutions. by removing the sunset clause, allowing long-term planning for multi-year research projects and investments without fear of imminent program shutdown.

  3. Signals New York’s ongoing commitment to scientific innovation and public health. , helping the state attract and retain top research talent and biotech companies, and reinforcing its leadership role in biomedical research.

  4. Removes uncertainty for patients and advocacy groups. who rely on progress in stem cell therapies, ensuring that advocacy, funding, and ethical oversight remain in place for future developments.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Keep Stem Cell Board

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Brad Hoylman-Sigal

Senator · Senate District 47

Chair, Judiciary

1 Co-sponsor

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A3433Assembly

Extend Stem Cell Board

In Assembly Committee · Health · Sponsor Rebecca Seawright

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

554

2023-2024 Regular Sessions

IN SENATE

January 5, 2023

Introduced by Sens. HOYLMAN, KRUEGER -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law and part H of chapter 58 of the laws of 2007 amending the public health law, the public officers law and the state finance law relating to establishing the empire state stem cell board, in relation to the continuation of the empire state stem cell board

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 1 of section 265-a of the public health law, as amended by section 1 of part M of chapter 57 of the laws of 2021, is amended to read as follows:

1. The empire state stem cell board ("board"), comprised of a funding committee and an ethics committee, both of which shall be chaired by the commissioner, is hereby created within the department for the purpose of administering the empire state stem cell trust fund ("fund"), created pursuant to section ninety-nine-p of the state finance law. The board is hereby empowered, subject to annual appropriations and other funding authorized or made available, to make grants to basic, applied, translational or other research and development activities that will advance scientific discoveries in fields related to stem cell biology[; provided, however, that the board shall not make any grants on or after April first, two thousand twenty-one].

§ 2. Section 4 of part H of chapter 58 of the laws of 2007 amending the public health law, the public officers law and the state finance law relating to establishing the empire state stem cell board, as amended by section 2 of part M of chapter 57 of the laws of 2021, is amended to read as follows:

§ 4. This act shall take effect immediately and shall be deemed to have been in full force and effect on and after April 1, 2007 [and shall expire and be deemed repealed December 31, 2025].

§ 3. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00425-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law and part H of chapter 58 of the laws of 2007 amending the public health law, the public officers law and the state finance law relating to establishing the empire state stem cell board, in relation to the continuation of the empire state stem cell board

Summary of provisions

Section 1 of the bill amends subdivision 1 of section 265-a of the Public Health Law to repeal language adopted in the FY 2021-2022 State Budget that limits the Empire State Stem Cell Board from making any grants on or after April 1, 2021.

Section 2 of the bill amends section 4 of Part H of Chapter 58 of the Laws of 2007 amending the Public Health Law, the Public Officers Law and the State Finance Law relating to establishing the Empire State Stem Cell Board to repeal language adopted in the FY 2021-2022 State Budget that end the Empire State Stem Cell Board effective December 31, 2027.

Section 3 of the bill is the effective date.

Justification

Since 2007, the NYSTEM program has funded cutting-edge stem cell research and positioned New York State as a global leader in regenera- tive medicine research. Since its creation, NYSTEM has attracted more than $160 million in additional grant funding, over $250 million in venture capital investment and supported more than 750 jobs across the state.

Ending the NYSTEM program will damage the State's reputation as a leader in scientific research and cut off an important pipeline for ground- breaking research, attracting world-class scientists, and generating innovation.

This legislation would preserve the existence of NYSTEM and restore its grant-making power subject to appropriations in future State budgets.

Legislative history

S.6623-A of 2021-2022 (Hoylman): Died in Health

A.7984 of 2021-2022 (Seawright): Died in Health

Fiscal implications

To be determined.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.